These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20854827)

  • 1. Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy.
    Peña JR; Szkudlarek AC; Warren CM; Heinrich LS; Gaffin RD; Jagatheesan G; del Monte F; Hajjar RJ; Goldspink PH; Solaro RJ; Wieczorek DF; Wolska BM
    J Mol Cell Cardiol; 2010 Dec; 49(6):993-1002. PubMed ID: 20854827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.
    Jagatheesan G; Rajan S; Petrashevskaya N; Schwartz A; Boivin G; Arteaga GM; Solaro RJ; Liggett SB; Wieczorek DF
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H949-58. PubMed ID: 17416600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosis.
    Sheehan KA; Arteaga GM; Hinken AC; Dias FA; Ribeiro C; Wieczorek DF; Solaro RJ; Wolska BM
    J Mol Cell Cardiol; 2011 Mar; 50(3):442-50. PubMed ID: 21047515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
    Abraham TP; Jones M; Kazmierczak K; Liang HY; Pinheiro AC; Wagg CS; Lopaschuk GD; Szczesna-Cordary D
    Cardiovasc Res; 2009 Apr; 82(1):84-92. PubMed ID: 19150977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy.
    Evans CC; Pena JR; Phillips RM; Muthuchamy M; Wieczorek DF; Solaro RJ; Wolska BM
    Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2414-23. PubMed ID: 11045979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.
    Gaffin RD; Peña JR; Alves MS; Dias FA; Chowdhury SA; Heinrich LS; Goldspink PH; Kranias EG; Wieczorek DF; Wolska BM
    J Mol Cell Cardiol; 2011 Nov; 51(5):812-20. PubMed ID: 21840315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
    Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N.
    Gaffin RD; Chowdhury SA; Alves MS; Dias FA; Ribeiro CT; Fogaca RT; Wieczorek DF; Wolska BM
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1646-55. PubMed ID: 21743000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy.
    Schulz EM; Wilder T; Chowdhury SA; Sheikh HN; Wolska BM; Solaro RJ; Wieczorek DF
    J Biol Chem; 2013 Oct; 288(40):28925-35. PubMed ID: 23960072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
    Kazmierczak K; Paulino EC; Huang W; Muthu P; Liang J; Yuan CC; Rojas AI; Hare JM; Szczesna-Cordary D
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H575-89. PubMed ID: 23748425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts--role of myofilament Ca2+ sensitivity increase.
    Sirenko SG; Potter JD; Knollmann BC
    J Physiol; 2006 Aug; 575(Pt 1):201-13. PubMed ID: 16777946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo.
    O'Donnell JM; Fields A; Xu X; Chowdhury SA; Geenen DL; Bi J
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2483-94. PubMed ID: 18952713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CaMKII-mediated phosphorylation of RyR2 plays a crucial role in aberrant Ca
    Okuda S; Sufu-Shimizu Y; Kato T; Fukuda M; Nishimura S; Oda T; Kobayashi S; Yamamoto T; Morimoto S; Yano M
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1250-1256. PubMed ID: 29402414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.
    Asahi M; Otsu K; Nakayama H; Hikoso S; Takeda T; Gramolini AO; Trivieri MG; Oudit GY; Morita T; Kusakari Y; Hirano S; Hongo K; Hirotani S; Yamaguchi O; Peterson A; Backx PH; Kurihara S; Hori M; MacLennan DH
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9199-204. PubMed ID: 15201433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts.
    Rice R; Guinto P; Dowell-Martino C; He H; Hoyer K; Krenz M; Robbins J; Ingwall JS; Tardiff JC
    J Mol Cell Cardiol; 2010 May; 48(5):979-88. PubMed ID: 20004663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
    Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart.
    Zheng M; Dilly K; Dos Santos Cruz J; Li M; Gu Y; Ursitti JA; Chen J; Ross J; Chien KR; Lederer JW; Wang Y
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H424-33. PubMed ID: 12969887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age- and strain-related aberrant Ca
    Rowlands CT; Owen T; Lawal S; Cao S; Pandey SS; Yang HY; Song W; Wilkinson R; Alvarez-Laviada A; Gehmlich K; Marston SB; MacLeod KT
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1213-H1226. PubMed ID: 28887330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy.
    Wilder T; Ryba DM; Wieczorek DF; Wolska BM; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1720-30. PubMed ID: 26432840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.